FDA Inspection 1227976 — R.D. Laboratories Inc.

R.D. Laboratories Inc. — FEI 1937815

The FDA completed an inspection of R.D. Laboratories Inc. on January 26, 2024 in Washington, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 26, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Washington, MO (United States)